Organon pleasantly surprised me with its financial results for Q4 2024. Read why I believe OGN is an attractive stock for ...

We recently published a list of 10 Deep Value Stocks to Buy Now. In this article, we are going to take a look at where ...

Organon & Co. (NYSE:OGN – Get Free Report) has been given a consensus rating of “Hold” by the seven brokerages that are ...

JERSEY CITY, N.J., March 08, 2025--Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, today announced results from an analysis of the Phase 3 ADORING 3 open-label ...

Organon & Co. (NYSE:OGN), a global healthcare company spun off from Merck (NSE:PROR) in 2021, has established itself as a leader in women's health while expanding its presence in biosimilars and ...

Larson Financial Group LLC grew its holdings in Organon & Co. (NYSE:OGN – Free Report) by 345.4% in the fourth quarter, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Organon & Co.'s (NYSE:OGN) investors are due to receive a payment of $0.28 per share on 13th of March. Based on this payment, the dividend yield on the company's stock will be 7.3%, which is an ...

Organon (OGN) announced results from an analysis of the Phase 3 ADORING 3 open-label, long-term extension study evaluating VTAMA cream, 1% once ...

Recognizing the critical importance of women’s health in driving economic and social development, Organon (Thailand) Company ...

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Organon (OGN – Research Report), with a price target of ...